Background/Aims Renal ischemia followed by reperfusion (I/R) is a leading cause of acute kidney injury (AKI). which is closely associated with high morbidity and mortality. Studies have shown that induced pluripotent stem cell (iPSC)-derived mesenchymal stem cells (iMSCs) exert powerful therapeutic effects in renal ischemia. However. https://stilleners.shop/product-category/exterior/